Bath & Body Works, Inc. (NYSE:BBWI) Shares Sold by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System trimmed its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 42.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 60,700 shares of the company's stock after selling 45,200 shares during the period. Louisiana State Employees Retirement System's holdings in Bath & Body Works were worth $1,840,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of BBWI. Northwest Bank & Trust Co grew its holdings in shares of Bath & Body Works by 2.9% during the fourth quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock valued at $533,000 after buying an additional 419 shares during the last quarter. Nicolet Bankshares Inc. grew its holdings in shares of Bath & Body Works by 2.8% during the fourth quarter. Nicolet Bankshares Inc. now owns 17,232 shares of the company's stock valued at $668,000 after buying an additional 463 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Bath & Body Works by 15.5% during the first quarter. Blue Trust Inc. now owns 4,184 shares of the company's stock valued at $127,000 after buying an additional 560 shares during the last quarter. WINTON GROUP Ltd grew its holdings in shares of Bath & Body Works by 1.6% during the fourth quarter. WINTON GROUP Ltd now owns 36,384 shares of the company's stock valued at $1,411,000 after buying an additional 577 shares during the last quarter. Finally, TD Private Client Wealth LLC grew its holdings in shares of Bath & Body Works by 34.9% during the fourth quarter. TD Private Client Wealth LLC now owns 2,290 shares of the company's stock valued at $89,000 after buying an additional 593 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Up 0.3%

Shares of Bath & Body Works stock traded up $0.08 during mid-day trading on Friday, hitting $31.79. The stock had a trading volume of 4,055,565 shares, compared to its average volume of 5,252,643. The firm has a 50-day moving average of $30.16 and a two-hundred day moving average of $32.30. Bath & Body Works, Inc. has a 12-month low of $24.94 and a 12-month high of $41.87. The firm has a market cap of $6.73 billion, a P/E ratio of 8.48, a price-to-earnings-growth ratio of 1.06 and a beta of 1.72.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter last year, the firm earned $0.38 EPS. The firm's revenue for the quarter was up 2.9% on a year-over-year basis. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Shareholders of record on Friday, June 6th were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, June 6th. This represents a $0.80 annualized dividend and a yield of 2.52%. Bath & Body Works's dividend payout ratio is presently 21.33%.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on BBWI shares. Citigroup lifted their price target on shares of Bath & Body Works from $36.00 to $42.00 and gave the stock a "buy" rating in a research note on Tuesday, May 20th. Wells Fargo & Company lifted their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, May 14th. The Goldman Sachs Group reduced their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating on the stock in a report on Friday, May 30th. Morgan Stanley reduced their price target on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating on the stock in a report on Tuesday, May 6th. Finally, Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company's stock. Based on data from MarketBeat, Bath & Body Works currently has a consensus rating of "Moderate Buy" and an average target price of $42.00.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.